← Back to Search

Behavioral Intervention

Intervention for Postoperative Complications

N/A
Recruiting
Led By Daniel McIsaac, MD
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Scheduled, or on the pathway, for inpatient abdominal, thoracic, pelvic, head-and-neck or vascular surgery
Age ≥18 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

"This trial is looking at how well people can be recruited, stick to the program, and be followed up on while participating in a home-based prehabilitation program before surgery. Half of the participants will

Who is the study for?
This trial is for adults over 18 who are scheduled for inpatient abdominal, thoracic, pelvic, head-and-neck or vascular surgery within the next 3 to 12 weeks. Participants must have a valid health insurance number and access to an internet-enabled device with an email address.Check my eligibility
What is being tested?
The STRIVE Trial is testing a home-based prehabilitation program delivered through an online platform before surgery. Participants are randomly placed into either the prehabilitation group or a control group to compare outcomes.See study design
What are the potential side effects?
Since this trial involves a non-invasive prehabilitation intervention rather than medication, traditional side effects like those seen with drugs may not apply. However, participants might experience fatigue or discomfort from increased physical activity.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am scheduled for surgery in my abdomen, chest, pelvis, head-and-neck, or vascular system.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Elicitation of patient, clinician and researcher-identified barriers
Intervention adherence
Monthly recruitment
+2 more
Secondary outcome measures
Days at home (to be merged with larger trial)
Emergency department visits (to be merged with larger trial)
Health Related Quality of Life using the EQ-5D-5L (to be merged with larger trial)
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
The intervention includes 3 aspects (exercise, nutrition and breathing). Our intervention is a home-based multimodal prehabilitation program supported through an online platform.
Group II: ControlActive Control1 Intervention
To support blinding, improve enrollment and reflect usual care, widely available physical activity (World Health Organization Recommendations for Physical Activity for ages 18-64 and >65) and healthy eating recommendations (Canada's Food Guide Snapshot) documents will be provided to control participants (without active or online support).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prehabilitation intervention
2021
N/A
~120

Find a Location

Who is running the clinical trial?

Ottawa Hospital Research InstituteLead Sponsor
561 Previous Clinical Trials
2,785,350 Total Patients Enrolled
3 Trials studying Postoperative Complications
16,089 Patients Enrolled for Postoperative Complications
Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,345 Previous Clinical Trials
26,453,370 Total Patients Enrolled
Daniel McIsaac, MDPrincipal InvestigatorThe Ottawa Hospital
1 Previous Clinical Trials
90 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available openings for patients to participate in this medical study?

"Indeed, the details on clinicaltrials.gov highlight that this investigation is actively seeking suitable participants. Initially shared on January 30th, 2024, and last modified on January 31st, 2024, the trial aims to enroll a total of 144 patients from one designated site."

Answered by AI

What is the current number of individuals being recruited for participation in this research endeavor?

"Yes, data from clinicaltrials.gov indicates that this trial is presently enrolling participants. The trial was first listed on January 30th, 2024 and last modified on January 31st, 2024. It aims to recruit a total of 144 patients across one site."

Answered by AI

What are the anticipated results that researchers hope to achieve through this experimental investigation?

"The main focus of this research, to be assessed over a 12-month duration, is patient retention. Additionally, secondary endpoints include non-home discharge (to be integrated into a broader study), characterized by transfer from the initial hospitalization site or mortality; emergency department visits (to be amalgamated with an expanded investigation), measured as the total number of such visits; and length of stay (to be consolidated within a larger trial), denoting the period between surgical admission and discharge."

Answered by AI
~96 spots leftby Jan 2025